During the past decade, Hospital Civil de Culiacan conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Civil de Culiacan" are "COVID-19" (1 trials) and "Covid-19" (1 trials). Many other conditions were trialed in "Hospital Civil de Culiacan" in a lesser frequency.

Most popular intervention types in "Hospital Civil de Culiacan" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (1 trials), "Apremilast placebo" (1 trials), "CPI-006 1 mg/kg + SOC" (1 trials), "CPI-006 2 mg/kg + SOC" (1 trials) and "Lanadelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Civil de Culiacan" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Civil de Culiacan". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Civil de Culiacan, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Civil de Culiacan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Hospital Civil de Culiacan has several departments that took part in Clinical trials: "Hospital General De Culiacan; Servicio De Hematologia" - 3 trials